Hartmut Goldschmidt
Impact in
- Hematology top 0.01%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 0.1%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 553
- Multiple Myeloma Research and Treatments 520
- Hematopoietic Stem Cell Transplantation 54
-
- Protein Degradation and Inhibitors 170
- Amyloidosis: Diagnosis, Treatment, Outcomes 65
- Glycosylation and Glycoproteins Research 37
- Co-authors
- Anthony D. Ho (137 shared papers)Dirk Hose (130 shared papers)Kai Neben (65 shared papers)Pieter Sonneveld (51 shared papers)Jens Hillengaß (104 shared papers)Ute Hegenbart (70 shared papers)Thomas Moehler (53 shared papers)Bernard Klein (60 shared papers)
- Journals
- Blood (160 papers)Journal of Clinical Oncology (46 papers)British Journal of Haematology (23 papers)Haematologica (21 papers)Leukemia (18 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Hartmut Goldschmidt
623 papers receiving 18.0k citations
Hartmut Goldschmidt's Hit Papers
Peers
Comparison fields: 5 of 143
- Hematology 12.5k
- Oncology 8.0k
- Genetics 2.2k
- Molecular Biology 10.1k
- Immunology 1.9k
Countries citing papers authored by Hartmut Goldschmidt
This map shows the geographic impact of Hartmut Goldschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hartmut Goldschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hartmut Goldschmidt more than expected).
Fields of papers citing papers by Hartmut Goldschmidt
This network shows the impact of papers produced by Hartmut Goldschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hartmut Goldschmidt. The network helps show where Hartmut Goldschmidt may publish in the future.
Co-authors
The 25 scholars most cited alongside Hartmut Goldschmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 660 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2017 | 518 |
| 2 | Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† Hit paper breakdown → | 2021 | 460 |
| 3 | IMWG consensus on risk stratification in multiple myeloma Hit paper breakdown → | 2013 | 413 |
| 4 | 1994 | 409 | |
| 5 | 2017 | 281 | |
| 6 | 2010 | 255 | |
| 7 | 2009 | 232 | |
| 8 | 2010 | 223 | |
| 9 | 2012 | 198 | |
| 10 | 2005 | 197 | |
| 11 | 2008 | 196 | |
| 12 | 2006 | 191 | |
| 13 | 2009 | 190 | |
| 14 | 2018 | 183 | |
| 15 | 2013 | 181 | |
| 16 | 2016 | 177 | |
| 17 | 2006 | 176 | |
| 18 | 2010 | 173 | |
| 19 | 2013 | 171 | |
| 20 | 2004 | 171 |
About Hartmut Goldschmidt
Hartmut Goldschmidt is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Immunology, having authored 660 papers that have together received 18.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (520 papers), Protein Degradation and Inhibitors (170 papers), Cancer Treatment and Pharmacology (107 papers), Peptidase Inhibition and Analysis (81 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (65 papers), Hematopoietic Stem Cell Transplantation (54 papers), Chronic Lymphocytic Leukemia Research (48 papers) and Glycosylation and Glycoproteins Research (37 papers). The work is most often cited by research in Hematology (12.5k citations), Oncology (8.0k citations), Genetics (2.2k citations), Molecular Biology (10.1k citations) and Immunology (1.9k citations). Hartmut Goldschmidt has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Anthony D. Ho, Dirk Hose, Kai Neben, Pieter Sonneveld, Jens Hillengaß, Ute Hegenbart, Thomas Moehler, Bernard Klein, Meletios Α. Dimopoulos and Gerlinde Egerer. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Haematologica and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.